Biologic Drug Prices in Medicare Part B After Entry of Biosimilars to the Market
This cohort study evaluates the associations of biosimilar entry to the market with the prices of originator biologics under Medicare Part B reimbursement.
Our new study is out today in @jamanetworkopen.com!
We looked at trends in biologic drug prices after biosimilar competition.
Key takeaways: savings from biosimilars are substantial, but take longer to accrue than commonly seen with generic small molecules.
1/
jamanetwork.com/journals/jam...
11.11.2025 17:39 β π 6 π 3 π¬ 1 π 1
What's the meaning? π€
28.10.2025 17:52 β π 0 π 0 π¬ 0 π 0
It's probably an unpopular opinion, but the more I do research, the more I realize that it's almost IMPOSSIBLE to do transparent and reproducible research without strong programming skills.
03.07.2025 18:53 β π 7 π 1 π¬ 2 π 2
Will the recordings be available on YouTube after the event?
27.05.2025 20:08 β π 1 π 0 π¬ 1 π 0
I am trying to access the newest version of
@miguelhernan.bsky.social 's Causal Inference What If book, but it seems that Harvard's SPH website no longer shows it.
Any idea how to get to the old page?
#EpiSky
11.12.2024 15:48 β π 2 π 0 π¬ 2 π 0
Is there an advantage to go deep into rust compared to C++ for the R user?
01.12.2024 18:35 β π 1 π 0 π¬ 1 π 0
A random snapshot of my Zotero account, showing that nearly all the papers are from arxiv
I've never, personally, had any direct utility from traditional academic peer review for my scientific work.
I've never used that peer review as any kind of signal or credential in judging a paper or deciding whether to read it.
Nearly all the papers I read are preprints.
25.11.2024 02:01 β π 246 π 17 π¬ 15 π 10
I think it would be easier to use dput()
21.11.2024 23:20 β π 0 π 0 π¬ 0 π 0
This reminds me of days navigating why I have a much smaller sample size while building a cohort for my study. It turns out that Excel removes leading zeroes in MRNs, and many patients can not be linked. Ironically, ppl out there might accuse you of complicating things when you use R
25.09.2024 03:00 β π 1 π 0 π¬ 0 π 0
For the 2nd equation to work, you assume some kind of equal confounding i.e.
Somehow A <- U -> Y has the same direction and magnitude to A <- U -> W
Correct?
05.09.2024 23:46 β π 0 π 0 π¬ 1 π 0
So the goal of the first equation to kind of isolate the association presented in the DAG as A <- U -> W then using it. This is why you put Z. Otherwise, your association would capture the path A <- Z -> U -> W too. Did I get it?
05.09.2024 23:42 β π 0 π 0 π¬ 1 π 0
Illustration showing rows in a dataframe getting grouped, then adding a new column
Illustration showing rows in a dataframe getting grouped, summarized, and ungrouped
Illustration showing rows in a dataframe getting grouped into two groups, then summarized and ungrouped
Note from the blog post showing links to download all these videos
New blog post! Seven (7!) new tidyexplain-esque animations showing how {dplyr}'s mutate(), summarize(), group_by(), and ungroup() all work together #rstats #dataskyence www.andrewheiss.com/blog/2024/04...
04.04.2024 21:17 β π 68 π 31 π¬ 1 π 2
24.12.2023 03:07 β π 16 π 3 π¬ 0 π 0
Can you elaborate please?
15.12.2023 17:43 β π 0 π 0 π¬ 0 π 0
#Biologist interested in #immunity and host #pathogen interactions @ University of Exeter, UK, using #Drosophila: more than melanogaster whenever possible. He/him [β¦]
π bridged from β https://fediscience.org/@MarkHanson, follow @ap.brid.gy to interact
Statistician at the Leiden University Medical Center in the Netherlands.
Interested in data
Currently pharmacometrics and causal inference
Legacy: drug design, risk management, protein structures, protein folding, ...
https://scholar.google.com/citations?user=R3QYvdUAAAAJ
Mostly stats, visualization, open science, and psychotherapy.
https://rpsychologist.com
Health services researcher at Vanderbilt Health Policy. Avid coffee drinker, investigator of drug policies & prices. RT not an endorsement. Opinions are mine.
Medical oncologist and health services researcher. Focusing on health care costs, physician-industry COI, and oncology reimbursement reform. Opinions mine.
Consultant in Public Health at Bradford Institute for Health Research. Interested in quantitative research methods and mental health
Professor at Temple University, PA. Interested in Psychological Assessment, Psychometrics, Statistics, Psychotherapy, R
Software Engineer at Posit PBC.
I mostly post about R, Python, and Deep Learning.
Github: https://github.com/t-kalinowski
π your entire analytics engineering workflow.
Learn more at http://getdbt.com
Senior Machine Learning Scientist at OneSix, formerly U of Michigan, Notre Dame. Enjoys extracting meaning from models. Future author of Models Demystified.
https://m-clark.github.io/
Annual Workshop Organised by the Monash Business Analytics Team.
29th-30th September 2025
wombat2025.numbat.space
Criminologist | Researcher in cybercrime @nscr-instituut.bsky.social & The Hague University of Applied Sciences | Co-Chair @opencriminology.bsky.social
π: asiermoneva.com
π¬: π¬π§πͺπΈπ³π±
π: Amsterdam - The Hague
Prof Quantitative Criminology QUB.
Director, MethodsLab @ SSESW.
Interested in things like adolescent alcohol and drug use; cyber victimisation and harm; prevention; latent variable modeling & longitudinal research.
Comp. sci. prof. @ American University, Washington DC. AI & games researcher with miscellaneous other interests. https://www.kmjn.org/
Assistant Professor at NYU Politics
Assistant Professor of Political Science, UW Madison.
Asst. Prof. of Statistics & Political Science at Penn State. I study stats methods, gerrymandering, & elections. Bayesian. Founder of UGSDW and proud alum of HGSU-UAW L. 5118.
corymccartan.com
@UTAustin
"Nullius in verba"
Book β planetarycausalinference.org/launch
Jobs β aidevlab.org/jobs
Assistant Professor of Political Science, University of Michigan. Affiliated with the Center for Political Studies, the Michigan Institute for Data Science, and the Center for Japanese Studies. Website: https://shiraito.github.io